News search

E.g., 22/11/2026
E.g., 22/11/2026
The R33Q mutation in calsequestrin 2 (CASQ2) disrupts calcium control in heart cells and activates protein-degradation mechanisms.
Research
23 Sep 2026

Researchers at the CNIC, in collaboration with the University of Pavia and IRCCS Istituti Clinici Scientifici Maugeri, have found that activation of the enzyme calpain contributes to the development of a severe inherited arrhythmia.

Diana Velázquez, Natalia Vicente, Jon Sicilia, María Rosaria Pricolo, Laura Sen, Jorge Alegre y Agata Bak.
Research
7 Jul 2026

Hypertrophic cardiomyopathy is the most common inherited heart disease and the leading cause of sudden cardiac death in young people and athletes

De izquierda a derecha y de arriba hacia abajo: Maria Rosaria Pricolo, Natalia Vicente, Verónica Labrador, Olga Giménez, Manuel Gavilán, Jon Sicilia, Jesús Vázquez, Elías Herrero, Roberto Silva, Jorge Alegre y Diana Velázquez.
Research
5 Jun 2025

This new tool will advance the development of treatments for congenital muscle diseases and cardiomyopathies. 

Juan Pablo Ochoa, Pablo García-Pavía, Laura Lalaguna, Marina López-Olañeta, María Arévalo-Núñez de Arenas y Enrique Lara-Pezzi.
Research
9 Apr 2025

A CNIC team has developed an innovative gene therapy strategy for arrhythmogenic right ventricular cardiomyopathy type 5 (ARVC5), a rare and deadly inherited condition that particularly affects young men

Fernando de Frutos y el Dr. Pablo García Pavía.
Research
29 Aug 2022

The findings, published in the Journal of the American College of Cardiology (JACC), represent a first step towards the personalized treatment of patients with this disease